Nifty
Sensex
:
:
13258.55
45079.55
124.65 (0.95%)
446.90 (1.00%)

Pharmaceuticals & Drugs - API

Rating :
77/99

BSE: 524348 | NSE: AARTIDRUGS

752.00
04-Dec-2020
  • Open
  • High
  • Low
  • Previous Close
  •  745.30
  •  756.95
  •  725.10
  •  742.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1164230
  •  8653.98
  •  1026.95
  •  105.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 7,003.98
  • 28.31
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,375.69
  • 0.07%
  • 7.93

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 60.21%
  • 1.54%
  • 31.52%
  • FII
  • DII
  • Others
  • 2.19%
  • 1.85%
  • 2.69%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.68
  • 9.64
  • 13.24

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.40
  • 8.11
  • 5.63

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.66
  • 15.52
  • 19.77

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.49
  • 16.37
  • 15.50

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.48
  • 3.40
  • 3.43

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.21
  • 10.04
  • 10.23

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
578.11
477.50
21.07%
544.67
405.43
34.34%
449.64
459.14
-2.07%
473.51
380.11
24.57%
Expenses
461.67
409.20
12.82%
410.70
350.71
17.11%
378.33
403.23
-6.18%
406.02
328.26
23.69%
EBITDA
116.44
68.30
70.48%
133.97
54.72
144.83%
71.31
55.91
27.54%
67.49
51.85
30.16%
EBIDTM
20.14%
14.30%
24.60%
13.50%
15.86%
12.18%
14.25%
13.64%
Other Income
0.29
0.19
52.63%
1.26
0.06
2,000.00%
0.98
1.22
-19.67%
0.25
0.17
47.06%
Interest
7.05
8.54
-17.45%
6.57
9.33
-29.58%
7.47
10.34
-27.76%
8.39
10.48
-19.94%
Depreciation
12.56
12.09
3.89%
12.38
11.81
4.83%
12.49
10.81
15.54%
12.36
10.72
15.30%
PBT
97.12
47.86
102.93%
116.28
33.64
245.66%
60.71
39.75
52.73%
43.08
30.81
39.82%
Tax
21.85
15.55
40.51%
30.83
11.18
175.76%
1.85
12.31
-84.97%
15.30
9.94
53.92%
PAT
75.27
32.31
132.96%
85.45
22.46
280.45%
58.86
27.44
114.50%
27.78
20.87
33.11%
PATM
13.02%
6.77%
15.69%
5.54%
13.09%
5.98%
5.87%
5.49%
EPS
8.08
3.47
132.85%
9.17
2.41
280.50%
6.32
2.94
114.97%
2.98
2.24
33.04%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Mar 08
Net Sales
2,045.93
1,806.09
1,560.94
1,243.63
1,195.17
1,139.84
1,096.88
501.05
478.50
382.12
312.36
Net Sales Growth
18.80%
15.71%
25.51%
4.05%
4.85%
3.92%
118.92%
4.71%
25.22%
22.33%
 
Cost Of Goods Sold
1,271.11
1,127.29
1,013.53
737.72
744.43
735.08
724.24
321.34
301.35
238.85
197.35
Gross Profit
774.82
678.79
547.40
505.91
450.75
404.77
372.65
179.71
177.15
143.27
115.01
GP Margin
37.87%
37.58%
35.07%
40.68%
37.71%
35.51%
33.97%
35.87%
37.02%
37.49%
36.82%
Total Expenditure
1,656.72
1,540.57
1,350.03
1,041.76
1,004.68
960.02
924.51
431.87
396.04
315.67
266.61
Power & Fuel Cost
-
103.83
84.39
71.42
59.42
53.93
49.56
29.07
26.48
23.27
19.70
% Of Sales
-
5.75%
5.41%
5.74%
4.97%
4.73%
4.52%
5.80%
5.53%
6.09%
6.31%
Employee Cost
-
61.35
54.55
52.14
47.95
40.19
33.26
19.93
14.77
12.00
10.54
% Of Sales
-
3.40%
3.49%
4.19%
4.01%
3.53%
3.03%
3.98%
3.09%
3.14%
3.37%
Manufacturing Exp.
-
160.38
142.69
130.01
103.21
87.60
75.53
39.18
32.32
25.17
24.22
% Of Sales
-
8.88%
9.14%
10.45%
8.64%
7.69%
6.89%
7.82%
6.75%
6.59%
7.75%
General & Admin Exp.
-
21.39
14.24
12.22
12.81
10.98
10.48
4.86
4.95
3.80
3.14
% Of Sales
-
1.18%
0.91%
0.98%
1.07%
0.96%
0.96%
0.97%
1.03%
0.99%
1.01%
Selling & Distn. Exp.
-
59.46
37.51
34.00
31.16
27.82
28.99
16.21
14.47
11.69
9.99
% Of Sales
-
3.29%
2.40%
2.73%
2.61%
2.44%
2.64%
3.24%
3.02%
3.06%
3.20%
Miscellaneous Exp.
-
6.88
3.11
4.24
5.71
4.42
2.45
1.27
1.71
0.89
9.99
% Of Sales
-
0.38%
0.20%
0.34%
0.48%
0.39%
0.22%
0.25%
0.36%
0.23%
0.53%
EBITDA
389.21
265.52
210.91
201.87
190.49
179.82
172.37
69.18
82.46
66.45
45.75
EBITDA Margin
19.02%
14.70%
13.51%
16.23%
15.94%
15.78%
15.71%
13.81%
17.23%
17.39%
14.65%
Other Income
2.78
1.48
2.41
1.05
4.00
0.00
0.65
0.16
0.63
0.52
1.85
Interest
29.48
37.42
43.51
38.36
40.02
48.02
42.28
17.12
18.66
26.45
14.48
Depreciation
49.79
48.75
42.56
40.06
38.46
36.53
31.02
19.11
17.03
14.48
13.02
PBT
317.19
180.82
127.26
124.50
116.01
95.27
99.72
33.11
47.40
26.04
20.09
Tax
69.83
43.89
41.27
42.20
34.21
26.55
22.47
9.61
18.96
8.47
5.28
Tax Rate
22.02%
23.69%
31.50%
33.90%
29.49%
27.87%
22.53%
29.02%
40.00%
32.53%
26.28%
PAT
247.36
141.40
89.75
82.31
81.80
68.72
77.25
23.50
28.06
16.71
14.08
PAT before Minority Interest
247.37
141.40
89.75
82.31
81.80
68.72
77.25
23.50
28.44
17.57
14.81
Minority Interest
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-0.38
-0.86
-0.73
PAT Margin
12.09%
7.83%
5.75%
6.62%
6.84%
6.03%
7.04%
4.69%
5.86%
4.37%
4.51%
PAT Growth
139.97%
57.55%
9.04%
0.62%
19.03%
-11.04%
228.72%
-16.25%
67.92%
18.68%
 
EPS
26.54
15.17
9.63
8.83
8.78
7.37
8.29
2.52
3.01
1.79
1.51

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Mar 08
Shareholder's Funds
652.49
543.45
455.43
400.13
357.40
308.15
163.16
146.45
123.45
111.53
Share Capital
23.30
23.58
23.58
23.86
24.22
24.22
12.11
12.11
11.71
11.71
Total Reserves
629.19
519.86
431.85
376.27
333.18
283.94
151.05
134.34
111.53
99.82
Non-Current Liabilities
299.31
321.06
312.31
296.59
243.78
211.03
290.20
209.85
210.70
233.12
Secured Loans
171.74
199.64
190.53
187.38
176.66
152.72
204.83
138.66
160.86
127.57
Unsecured Loans
8.57
8.57
12.17
14.17
14.57
10.75
62.65
50.16
31.35
89.58
Long Term Provisions
23.63
12.32
16.87
8.39
1.42
0.29
0.00
0.00
0.00
0.00
Current Liabilities
624.70
590.98
621.68
494.31
501.02
482.76
70.10
57.99
59.62
57.40
Trade Payables
329.55
242.63
258.73
196.97
184.90
166.72
65.30
50.18
54.78
54.50
Other Current Liabilities
132.83
82.94
56.42
51.00
43.80
41.53
1.77
1.68
1.33
0.80
Short Term Borrowings
157.73
263.25
305.64
244.66
258.41
252.43
0.00
0.00
0.00
0.00
Short Term Provisions
4.59
2.16
0.89
1.68
13.91
22.08
3.03
6.13
3.51
2.11
Total Liabilities
1,576.50
1,455.49
1,389.42
1,191.03
1,102.20
1,001.94
523.46
419.15
403.24
416.63
Net Block
643.81
624.86
602.39
581.09
493.42
448.46
247.84
208.20
205.24
189.94
Gross Block
1,030.97
970.09
909.20
848.13
725.47
685.21
393.33
332.42
309.85
277.70
Accumulated Depreciation
387.16
345.22
306.81
267.04
232.05
236.75
145.49
124.21
104.61
87.76
Non Current Assets
672.50
671.20
652.55
619.61
536.97
476.40
263.50
213.35
207.43
217.81
Capital Work in Progress
12.21
32.75
28.45
14.28
34.04
16.06
10.37
3.40
0.64
14.67
Non Current Investment
13.36
12.44
10.76
11.94
4.63
4.63
5.28
1.74
1.55
13.20
Long Term Loans & Adv.
3.12
1.15
10.95
12.30
4.88
7.24
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
904.00
784.29
736.86
571.42
565.23
525.54
259.96
205.81
195.80
198.80
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
325.40
246.61
278.21
209.63
178.35
164.20
91.83
64.41
60.52
66.21
Sundry Debtors
488.63
458.54
374.94
296.81
331.69
314.27
121.34
115.87
113.48
103.29
Cash & Bank
7.64
5.55
4.27
4.17
4.82
3.58
5.27
8.52
3.48
4.02
Other Current Assets
82.32
6.56
10.21
0.00
50.37
43.49
41.52
17.01
18.32
25.27
Short Term Loans & Adv.
75.50
67.02
69.23
60.81
50.37
43.49
40.62
16.01
17.52
24.49
Net Current Assets
279.30
193.31
115.19
77.11
64.20
42.78
189.86
147.82
136.18
141.39
Total Assets
1,576.50
1,455.49
1,389.41
1,191.03
1,102.20
1,001.94
523.46
419.16
403.23
416.65

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
250.74
143.09
69.77
174.75
133.29
104.59
20.56
59.12
64.90
28.39
PBT
185.29
131.02
124.50
116.01
95.27
99.72
33.11
47.40
26.04
20.09
Adjustment
86.84
75.20
75.12
71.63
79.30
69.40
38.76
38.77
41.71
27.51
Changes in Working Capital
19.49
-33.49
-105.19
8.47
-21.25
-49.58
-40.22
-13.27
2.39
-15.17
Cash after chg. in Working capital
291.62
172.74
94.44
196.11
153.33
119.53
31.65
72.90
70.14
32.43
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-40.88
-29.64
-24.67
-21.36
-20.03
-14.94
-11.09
-13.80
-5.24
-4.05
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-33.21
-61.67
-73.54
-106.98
-98.79
-107.01
-76.36
-30.46
-11.51
-33.16
Net Fixed Assets
-49.10
-62.81
-72.64
-92.88
-46.34
-322.27
-65.29
-22.98
-19.64
-21.98
Net Investments
-1.46
-1.68
1.18
-7.30
-0.01
13.50
-3.23
0.00
12.15
-12.18
Others
17.35
2.82
-2.08
-6.80
-52.44
201.76
-7.84
-7.48
-4.02
1.00
Cash from Financing Activity
-215.41
-80.07
3.92
-68.23
-33.26
1.46
52.55
-23.62
-53.92
3.61
Net Cash Inflow / Outflow
2.13
1.35
0.15
-0.45
1.24
-0.95
-3.25
5.04
-0.53
-1.16
Opening Cash & Equivalents
4.64
3.29
3.15
3.60
3.58
4.53
8.52
3.48
4.02
5.18
Closing Cash & Equivalent
6.77
4.64
3.29
3.15
4.82
3.58
5.27
8.52
3.49
4.02

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
70.01
57.61
193.12
167.72
147.58
127.25
67.37
60.47
52.63
47.61
ROA
9.33%
6.31%
6.38%
7.13%
6.53%
10.13%
4.99%
6.92%
4.29%
3.78%
ROE
23.65%
17.97%
19.24%
21.60%
20.65%
32.78%
15.18%
21.09%
14.97%
14.08%
ROCE
21.39%
17.01%
17.31%
18.50%
18.33%
23.93%
13.12%
20.30%
16.30%
11.03%
Fixed Asset Turnover
1.81
1.66
1.44
1.64
1.75
2.19
1.45
1.57
1.42
1.26
Receivable days
95.71
97.45
97.10
89.05
95.59
67.25
82.06
83.04
95.17
98.73
Inventory Days
57.80
61.36
70.52
54.97
50.69
39.52
54.05
45.23
55.64
69.71
Payable days
64.68
68.08
73.82
67.66
65.68
45.51
45.97
46.92
62.87
59.81
Cash Conversion Cycle
88.83
90.73
93.79
76.36
80.60
61.26
90.14
81.35
87.94
108.62
Total Debt/Equity
0.58
0.93
1.20
1.20
1.26
1.45
1.64
1.29
1.56
1.95
Interest Cover
5.95
4.01
4.25
3.90
2.98
3.36
2.93
3.54
1.98
2.39

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.